888 Holdings PLC

AGM Information • Apr 25, 2025

THIS DOCUMENT IS IMPORTANT AND REQUIRES YOUR IMMEDIATE ATTENTION.

If you are in any doubt as to any aspect of the proposals referred to in the document or about the action you should take, you are recommended to seek your own independent advice immediately from your stockbroker, bank manager, solicitor, accountant or other appropriately authorised independent professional adviser who is authorised under the Financial Services and Markets Act 2000 if you are in the United Kingdom or, if not, from another appropriately authorised independent adviser.

evoke plc (The "Company") (Registered in Gibraltar with company number 90099)

Notice of 2025 Annual General Meeting

Notice of Annual General Meeting

evoke plc

Registered office Suite 601/701 Europort Europort Road Gibraltar

Registered in Gibraltar with company number 90099

THIS DOCUMENT IS IMPORTANT AND REQUIRES YOUR IMMEDIATE ATTENTION.

If you are in any doubt as to any aspect of the proposals referred to in the document or about the action you should take, you are recommended to seek your own independent advice immediately from your stockbroker, bank manager, solicitor, accountant or other appropriately authorised independent professional adviser who is authorised under the Financial Services and Markets Act 2000 if you are in the United Kingdom or, if not, from another appropriately authorised independent adviser.

If you have sold or transferred all your ordinary shares (the "Ordinary Shares") or underlying depositary interests (the "Depositary Interests") in evoke plc ("evoke" or the "Company"), you should pass this letter and all other documents enclosed with it to the purchaser or transferee or to the stockbrokers, bank or other agent through whom the sale or transfer was effected for transmission to the purchaser or transferee as soon as possible.

Notice of the Annual General Meeting (the "Meeting") of evoke to be held at 9.00am UK time (10.00am Gibraltar time) on Wednesday 28 May 2025 is set out on pages 7 and 8 of this document.

The Meeting will take place at the office of Hudson Sandler LLP at 25 Charterhouse Square, London EC1M 6AE. Shareholders not able to attend in person will be able to follow the proceedings of the Meeting over the online Investor Meet Company platform by registering in advance via the following link:

https://www.investormeetcompany.com/evoke-plc/register-investor

Shareholders are invited to submit any questions in respect of the business of the Meeting for the Board to consider. Questions may be submitted in advance or during the Meeting over the Investor Meet Company platform following registration, and the Board will aim to respond to any such questions relevant to the business of the Meeting.

A live broadcast of the Meeting will be opened over the platform at approximately 8.55am UK time (9.55am Gibraltar time) on 28 May 2025. Shareholders joining over the platform will be able to see and hear the Meeting, but will not be seen or heard by the Board.

evoke plc is committed to reducing paper and improving efficiency in its shareholder communications. As was the case last year, you will not receive a hard copy form for the 2025 AGM in the post automatically. You may request a hard copy form directly from our Registrar, MUFG Corporate Markets (formerly Link Group). Details of how to request, and complete, a hard copy form are set out in notes on page 9 of this document. All instructions must be received by the Registrars by no later than 9.00am UK time (10.00am Gibraltar time) on 22 May 2024 for Depositary Interest Holders and Employee Shareholders and 9.00am UK time (10.00am Gibraltar time) on 23 May 2024 for Ordinary Shareholders.

You can submit your proxy appointment or voting instruction electronically by logging on to https://www.signalshares.com. Further details are set out in the notes on page 9.

If you wish to vote at the Meeting you are strongly encouraged to do so by submitting your proxy appointment or voting instruction in advance as appropriate. YOU WILL NOT BE ABLE TO VOTE AT THE MEETING OVER THE ONLINE PLATFORM.

The Board encourages shareholders to watch the Company's website and regulatory news services for any updates in relation to the Meeting that may need to be provided.

Ordinary Shareholders

A proxy appointment should be submitted electronically by logging on to https://www.signalshares.com or via the VOTE+ app as soon as possible and by no later than 9.00am UK time (10.00am Gibraltar time) on 23 May 2025. Alternatively, a hard copy form may be requested from the registrar, MUFG Corporate Markets, and should be completed and returned, in accordance with the instructions printed thereon, as soon as possible and by no later than 9.00am UK time (10.00am Gibraltar time) on 23 May 2025.

Depositary Interest Holders/Employee Shareholders

A voting instruction should be completed by Depositary Interest Holders and Employee Shareholders electronically by logging on to https://www.signalshares.com or via the VOTE+ app as soon as possible and by no later than 9.00am UK time (10.00am Gibraltar time) on 22 May 2025. Alternatively, a hard copy form may be requested from the registrar, MUFG Corporate Markets, and should be completed and returned, in accordance with the instructions printed thereon, as soon as possible and by no later than 9.00am UK time (10.00am Gibraltar time) on 22 May 2025.

Depositary Interest Holders who are CREST members may instruct the Depositary how to vote through the CREST electronic proxy appointment service may do so for the meeting and any adjournment(s) thereof by using the procedures described in the CREST Manual.

If you are an institutional investor, Depositary Interest Holders may also be able to submit an instruction electronically via the Proxymity platform, a process which has been agreed by the Company and approved by the Registrar. For further information regarding Proxymity, please go to www.proxymity.io.

Notice of Annual General Meeting continued

evoke plc Suite 601/701 Europort Europort Road Gibraltar

25 April 2025

To:

• the holders of Ordinary Shares (the "Ordinary Shareholders");
• the holders of Depositary Interests in Ordinary Shares held in uncertificated form through CREST (the "Depositary Interest Holders"); and
• the participants in the Company's All-Employee Share Plan, the Long Term Incentive Plan and the Deferred Share Bonus Plan (the "Employee Shareholders").

Dear Sir/Madam

2025 ANNUAL GENERAL MEETING

Our 2025 Annual General Meeting will be held on Wednesday 28 May 2025 at 9.00am UK time (10.00am Gibraltar time). The Meeting location will be the office of Hudson Sandler LLP at 25 Charterhouse Square, London EC1M 6AE.

The directors of the Company (the "Directors") strongly encourage you to fill in the Form of Proxy if you are an Ordinary Shareholder, or if you are Depositary Interest Holder or Employee Shareholder, the Form of Direction. Please see "Action to be taken" below for further details.

The Notice convening the Meeting is set out on pages 7 and 8 and I am writing to give you details of the items of business to be transacted at the Meeting.

The business of the Meeting will be to consider and if, thought fit, pass the resolutions set out on pages 8 to 10.

Resolutions 1 to 2

These resolutions deal with the Annual Report & Accounts 2024 (Resolution 1), and the Directors' Remuneration Report (Resolution 2). These resolutions will be proposed as ordinary resolutions.

Resolutions 3 to 11

These resolutions deal with the election and re-election of Directors. These resolutions will be proposed as ordinary resolutions.

Resolutions 12 to 14

These resolutions deal with the re-appointment of the auditors and the auditors' remuneration (Resolutions 12 and 13), and the Directors' authority to allot shares (Resolution 14). All these resolutions will be proposed as ordinary resolutions.

Resolutions 15 to 17

These resolutions deal with the authority for the Company to purchase its own shares (Resolution 15), and the authority of the Directors to disapply pre-emption rights, in line with UK institutional shareholder guidelines (Resolutions 16 and 17). These resolutions will be proposed as special resolutions.

An explanation of each of the resolutions is set out on pages 5 to 7 of this document.

Recommendation

Your Board unanimously recommends that shareholders vote in favour of all the resolutions set out in the Notice of the Meeting, which they consider to be in the best interests of the Company and the shareholders as a whole.

The Directors intend to vote in favour of all resolutions in respect of their beneficial shareholdings totalling 4,290,636 Ordinary Shares representing 0.95% of the issued share capital of the Company as at 28 February 2025 (being the latest practicable date prior to publication of this Notice).

Notice of Annual General Meeting continued

Action to be taken

Ordinary Shareholders

A proxy appointment should be submitted electronically by logging on to https://www.signalshares.com or via the VOTE+ app as soon as possible and by no later than 9.00am UK time (10.00am Gibraltar time) on 23 May 2025. Alternatively, a hard copy form may be requested from the registrar, MUFG Corporate Markets, and should be completed and returned, in accordance with the instructions printed thereon, as soon as possible and by no later than 9.00am UK time (10.00am Gibraltar time) on 23 May 2025.

Depositary Interest Holders and Employee Shareholders

A voting instruction should be completed by Depositary Interest Holders and Employee Shareholders electronically by logging on to https://www.signalshares.com or via the VOTE+ app as soon as possible and by no later than 9.00am UK time (10.00am Gibraltar time) on 22 May 2025. Alternatively, a hard copy form may be requested from the registrar, MUFG Corporate Markets, and should be completed and returned, in accordance with the instructions printed thereon, as soon as possible and by no later than 9.00am UK time (10.00am Gibraltar time) on 22 May 2024.

Depositary Interest Holders who are CREST members may instruct the Depositary how to vote through the CREST electronic proxy appointment service may do so for the meeting and any adjournment(s) thereof by using the procedures described in the CREST Manual.

If you are an institutional investor, Depositary Interest Holders may also be able to submit an instruction electronically via the Proxymity platform, a process which has been agreed by the Company and approved by the Registrar. For further information regarding Proxymity, please go to www.proxymity.io.

Yours faithfully

Lord Jon Mendelsohn Chairman

Explanation of business to be considered at the 2025 Annual General Meeting

The notes on the following pages give an explanation of the proposed resolutions.

Resolutions 1 to 14 are proposed as ordinary resolutions. This means that for each of those resolutions to be passed, more than half of the votes cast must be in favour of the resolution. Resolutions 15 to 17 are proposed as special resolutions. This means that for each of those resolutions to be passed, at least three-quarters of the votes cast must be in favour of the resolution.

Resolution 1: Annual Report & Accounts 2024

In accordance with the Gibraltar Companies Act, the Directors will present the Annual Report & Accounts for the financial year ended 31 December 2024 to the general meeting of shareholders.

Resolution 2: Directors' Remuneration Report

The Directors' Remuneration Report for the financial year ended 31 December 2024 is set out on pages 82–93 of the Company's Annual Report & Accounts 2024.

As the Company is Gibraltar incorporated, it is not required to prepare a directors' remuneration report pursuant to the UK Directors' Remuneration Report requirements in Schedule 8 to the UK Large and Medium-sized Companies and Groups (Accounts and Reports) Regulations 2008 (as amended) (the "DRR Regulations").

The Company has, however, prepared the Directors' Remuneration Report substantially in line with the requirements of the DRR Regulations on a voluntary basis as if the Company were required to do so, as a matter of good governance.

The shareholder vote on the Directors' Remuneration Report is advisory in nature and the Directors' entitlement to remuneration is not conditional on it. The Board will take the outcome of the vote into consideration in setting the Company's remuneration policy for its Directors.

Resolutions 3 to 11: Election and re-election of Directors

In accordance with the Company's Articles of Association, all Directors of the Company will retire at the Annual General Meeting and are offering themselves for re-election.

In proposing the election or re-election of the Directors, the Chairman has confirmed that, following formal performance evaluation, each individual continues to make an effective and valuable contribution to the Board and demonstrates commitment to the role.

Details of the Board evaluation process in relation to the Directors can be found on pages 68 and 71 of the Company's Annual Report & Accounts 2024.

Following a rigorous search process by the Nominations Committee, the Company seeks shareholder approval for the appointment of Non-Executive Director, Susan Standiford.

Biographical details of the current Directors are shown on pages 62–63 of the Company's Annual Report & Accounts 2024.

Resolution 12: Reappointment of auditors

The Company's independent auditors must be appointed or reappointed each year at the Annual General Meeting.

The Directors propose that, following the recommendation of the Audit & Risk Committee, Ernst & Young LLP and EY Limited, Gibraltar (together, "EY"), be reappointed as auditors, including for the purposes of meeting the Company's statutory requirements under Section 257 of the Gibraltar Companies Act, as amended, and the filing of the Company's financial statements in Gibraltar pursuant to Section 258 of the Gibraltar Companies Act 2014, as amended. EY has expressed its willingness to continue in office.

Resolution 13: Auditors' remuneration

Resolution 13 authorises the Audit & Risk Committee to determine the auditors' remuneration.

Resolution 14: Allotment of shares by Directors

Resolution 14 is proposed to renew the Directors' authority to allot relevant securities, in line with UK institutional shareholder guidelines. Paragraph (a)(i) of the resolution will allow the Directors to allot relevant securities up to a maximum nominal amount of £749,521.78 representing no more than one-third (33.33%) of the Company's Ordinary Share capital in issue as at 28 February 2025, being the latest practicable date prior to the publication of this Notice, such amount to be reduced by the nominal amount of any equity securities allotted under paragraph (a)(ii) in excess of £749,521.78. In accordance with institutional guidelines issued by The Investment Association, paragraph (a)(ii) of the resolution will allow Directors to allot, including the relevant securities referred to in paragraph (a)(i), further of the Company's shares in connection with a pre-emptive offer (including by way of a rights issue or open offer) to up to a maximum nominal amount of £1,499,043.56, representing no more than two-thirds (66.66%) of the Company's Ordinary Share capital in issue as at 28 February 2025, being the latest practicable date prior to the publication of this Notice, such amount to be reduced by any relevant securities allotted under paragraph (a)(i).

This authority will expire upon the earlier of: (i) the conclusion of the next Annual General Meeting of the Company after passing this resolution; and (ii) 30 June 2026.

The Directors have no present intention of exercising this authority. The Company does not hold any shares in treasury.

Resolution 15: Share buyback

Resolution 15 is to authorise the Company to purchase its own shares.

Background to and reasons for the Company to purchase its own shares

In certain circumstances it may be advantageous for the Company to purchase its own shares. The Board considers it desirable for the general authority to purchase its own shares to be available to provide maximum flexibility in the management of the Company's capital resources.

Explanation of business to be considered at the 2025 Annual General Meeting continued

Resolution 15: Share buyback continued

Pursuant to its Memorandum and Articles of Association and Section 105 of the Gibraltar Companies Act, the Company has the power to purchase its own shares. The resolution to be proposed at the Meeting will enable the Company, subject to certain limitations, to purchase shares in the market for cancellation. This authority will expire upon the earlier of: (i) the conclusion of the next Annual General Meeting of the Company after passing this resolution; and (ii) 30 June 2026, unless previously renewed, varied or revoked by the Company at a general meeting. Such authority would allow for purchases to be made on the terms set out in the resolution of up to a maximum number of 44,971,306 Ordinary Shares (representing no more than 10% of the issued Ordinary Share capital as at 28 February 2025, being the latest practicable date prior to the publication of this document).

The proposed maximum price (exclusive of expenses) which may be paid for each Ordinary Share will be the higher of: (i) an amount equal to 105% of the average of the middle market quotations of an Ordinary Share in the Company as derived from the London Stock Exchange Daily Official List for the five business days immediately preceding the day on which the Ordinary Share is contracted to be purchased; and (ii) an amount equal to the higher of the price of the last independent trade of an Ordinary Share and the highest current independent bid for an Ordinary Share in the Company as derived from the London Stock Exchange Trading System. The proposed minimum permitted price (exclusive of expenses) which may be paid for an Ordinary Share will be the nominal value of an Ordinary Share of £0.005.

A purchase of the proposed maximum of 44,971,306 Ordinary Shares at the share price of £0.684 (the closing market price on 28 February 2025) would involve the Company in expenditure of approximately £30,760,373.30 before commissions, and at the proposed minimum price of £0.005 would involve the Company in the expenditure, on the same basis, of approximately £224,856.53 before commissions.

Share options

As at 28 February 2025, there were outstanding options to subscribe for a total of 11,466,263 Ordinary Shares in the Company, representing approximately 2.5% of the Company's issued share capital at that time. If the Company were to exercise in full the proposed authority to purchase its own shares and prior to such purchase the Company's issued share capital remained unchanged, the shares for which there are outstanding options to subscribe would represent approximately 2.8% of the Company's issued Ordinary Share capital, as reduced by those purchases. The Company does not hold any treasury shares as at 28 February 2025.

General authority for the Company to purchase its own shares

The Directors intend to use the general share purchase authority with discretion and purchases would only be made from funds not required for other purposes and in light of market conditions prevailing at the time and other investment opportunities. The Directors will use this authority only after careful consideration, taking into account the Company's cash resources and capital, appropriate gearing levels and the overall position of the Company. The Directors will only purchase such shares if satisfied that it was in the interest of the shareholders as a whole to do so and would result in an increase in earnings per share and would benefit shareholders generally. No announcement will be made by the Company in advance of market purchases, but any purchases made by the Company would be announced by 7.30am UK time (8.30am Gibraltar time) on the business day next following the transaction.

Any purchases of Ordinary Shares would be by means of market purchases through the London Stock Exchange. Such Ordinary Shares would be automatically cancelled.

Resolution 16: General authority to disapply pre-emption rights

Resolution 16 seeks to renew the Directors' authority to allot equity securities for cash without first offering them to existing shareholders, in line with the latest UK institutional shareholder guidelines. Under Articles 19–26 of the Company's Articles of Association, if the Directors wish to allot Ordinary Shares, or grant rights to subscribe for, or convert securities into, Ordinary Shares, they must in the first instance offer them to existing shareholders in proportion to their holdings. Apart from rights issues or any other pre-emptive offer concerning equity securities, the authority would allow the Directors to issue shares for cash up to a maximum aggregate nominal amount of £112,428.27 representing 22,485,653 Ordinary Shares (representing no more than 5% of the Company's Ordinary Share capital in issue as at 28 February 2025, being the latest practicable date prior to the publication of this Notice) without first being required to offer such shares to existing shareholders.

This authority will expire upon the earlier of: (i) the conclusion of the next Annual General Meeting of the Company after passing this resolution; and (ii) 30 June 2026, save that the Company may before such expiry make an offer or agreement which would or might require equity securities to be allotted after such expiry and the Board may allot equity securities in pursuance of such an offer or agreement as if the power conferred hereby had not expired. The Directors have no present intention of exercising this authority.

Resolution 17: Additional authority to disapply pre-emption rights

Resolution 17 requests further shareholder approval, by way of a separate special resolution in line with the best practice guidance issued by the Pre-Emption Group, for the Directors to allot equity securities for cash without first being required to offer such securities to existing shareholders. The proposed resolution reflects the Pre-Emption Group 2023 Statement of Principles for the disapplication of pre-emption rights (the "Statement of Principles") and will expire on 30 June 2026 or at the conclusion of the next Annual General Meeting of the Company after the passing of this resolution, whichever is the earlier.

The authority granted by this resolution, if passed:

• a. will be limited to the allotment of equity securities up to an aggregate nominal value of £112,428.27 representing 22,485,653 Ordinary Shares, representing no more than 5% of the issued share capital of the Company as at 28 February 2025 (being the latest practicable date prior to publication of this Notice); and
• b. will only be used in connection with an acquisition or other capital investment of a kind contemplated by the Statement of Principles, and which is announced contemporaneously with the allotment, or has taken place in the preceding six-month period and is disclosed in the announcement of the allotment.

The authority granted by this resolution would be in addition to the general authority to disapply pre-emption rights under Resolution 16. The maximum nominal value of equity securities which could be allotted if both authorities were used would be £224,856.53 representing 44,971,306 Ordinary Shares, representing no more than 10% of the issued Ordinary Share capital of the Company as at 28 February 2025 (being the latest practicable date prior to publication of this Notice).

Notice of 2024 Annual General Meeting

evoke plc – no. 90099

NOTICE is hereby given that the Annual General Meeting of evoke plc will be held on Wednesday 28 May 2025 at 9.00am UK time (10.00am Gibraltar time) for the following purposes. The Meeting location will be the office of Hudson Sandler LLP at 25 Charterhouse Square, London EC1M 6AE.

Ordinary resolutions

• 1. To receive the Annual Report & Accounts 2024
• 2. To approve the Directors' Remuneration Report (other than the part containing the Remuneration Policy)
• 3. To re-elect Jon Mendelsohn as a Director
• 4. To re-elect Anne de Kerckhove as a Director
• 5. To re-elect Mark Summerfield as a Director
• 6. To re-elect Limor Ganot as a Director
• 7. To re-elect Andrea Gisle Joosen as a Director
• 8. To re-elect Ori Shaked as a Director
• 9. To re-elect Per Widerström as a Director
• 10.To re-elect Sean Wilkins as a Director
• 11. To elect Susan Standiford as a Director
• 12.To reappoint Ernst & Young LLP and EY Limited, Gibraltar, as the Company's auditors
• 13.To authorise the Audit & Risk Committee to agree the remuneration of the auditors

14.THAT:

• a. the Board be and it is hereby generally and unconditionally authorised to exercise all powers of the Company to allot relevant securities (within the meaning of Section 94 of the Gibraltar Companies Act 2014):
  • i. up to a maximum nominal amount of £749,521.78 (such amount to be reduced by the nominal amount of any equity securities allotted under paragraph (ii) below in excess of £749,521.78); and
  • ii. up to a maximum nominal amount of £749,521.78 (such amount to be reduced by any relevant securities allotted under paragraph (i) above) in connection with an offer or issue of equity securities pursuant to a pre-emptive offer (including an offer by way of a rights issue or open offer) to or in favour of:
    • a. Ordinary Shareholders where the equity securities respectively attributable to the interests of all Ordinary Shareholders are proportionate (as nearly as may be) to the respective numbers of Ordinary Shares held by them; and
    • b. holders of other equity securities if this is required by the rights of those securities, or if the Directors consider it necessary, as permitted by the rights of those securities,

and so that the Directors may make such exclusions or other arrangements as they consider expedient in relation to treasury shares, fractional entitlements, record dates, shares represented by depositary receipts, legal or practical problems under the laws in any territory or the requirements of any relevant regulatory body or stock exchange or any other matter;

b. this authority shall expire upon the earlier of: (i) the conclusion of the next Annual General Meeting of the Company after passing this resolution; and (ii) 30 June 2026, save that, in each case, the Company may before such expiry make an offer or agreement which would or might require relevant securities to be allotted after such expiry and the Board may allot relevant securities in pursuance of such an offer or agreement as if the authority conferred hereby had not expired. All previous unutilised authorities will cease to have effect.

Special resolutions

• 15.THAT the Company be and is hereby generally and unconditionally authorised, pursuant to Section 105 of the Gibraltar Companies Act (the "Act"), to make market purchases (within the meaning of Section 108 of the Act) of its Ordinary Shares of £0.005 each in the capital of the Company, subject to the following conditions:
  • i. the maximum number of Ordinary Shares authorised to be purchased is an aggregate nominal value of up to £224,856.53 (amounting to 44,971,306 Ordinary Shares as at the date of the Notice) (representing 10% of the present issued Ordinary Share capital as at 28 February 2025, being the latest practicable date prior to the publication of this document);
  • ii. the minimum price (exclusive of expenses) which may be paid for an Ordinary Share is £0.005 (being the nominal value of an Ordinary Share);
  • iii. the maximum price (exclusive of expenses) which may be paid for each Ordinary Share is the higher of:
    • a. an amount equal to 105% of the average of the middle market quotations of an Ordinary Share in the Company as derived from the London Stock Exchange Daily Official List for the five business days immediately preceding the day on which the Ordinary Share is contracted to be purchased; and
    • b. an amount equal to the higher of the price of the last independent trade of an Ordinary Share and the highest current independent purchase bid for an Ordinary Share in the Company as derived from the London Stock Exchange Trading System;
  • iv. this authority shall expire at the earlier of: (i) the conclusion of the next Annual General Meeting of the Company after passing this resolution; and (ii) 30 June 2026, unless previously renewed, varied or revoked by the Company at a general meeting; and

Notice of 2024 Annual General Meeting continued

• v. a contract to purchase shares under this authority may be made prior to the expiry of this authority, and concluded in whole or in part after the expiry of this authority, and the Company may purchase its Ordinary Shares in pursuance of any such contract as if the authority conferred hereby had not expired.
• 16.THAT the Board be and it is hereby empowered pursuant to Article 27 of the Company's Articles of Association (the "Articles") to allot equity securities (within the meaning of Article 25 of the Articles) for cash as if Articles 19–26 of the Articles did not apply to any such allotment provided that this power shall be limited:
• a. to the allotment of equity securities in connection with an offer or issue of equity securities by way of a rights issue pursuant to an authority granted under Resolution 13(a)(ii) to or in favour of:
  • i. Ordinary Shareholders where the equity securities respectively attributable to the interests of all Ordinary Shareholders are proportionate (as nearly as may be) to the respective numbers of Ordinary Shares held by them; and
  • ii. holders of other equity securities if this is required by the rights of those securities, or if the Directors consider it necessary, as permitted by the rights of those securities,

so that the Directors may make such exclusions or other arrangements as they consider expedient in relation to treasury shares, fractional entitlements, record dates, shares represented by depositary receipts, legal or practical problems under the laws in any territory or the requirements of any relevant regulatory body or stock exchange or any other matter; and

b. to the allotment (otherwise than pursuant to sub-paragraph (a) above) of equity securities up to an aggregate nominal value of £112,428.27.

This authority shall expire upon the earlier of: (i) the conclusion of the next Annual General Meeting of the Company after passing this resolution; and (ii) 30 June 2026, save that the Company may before such expiry make an offer or agreement which would or might require equity securities to be allotted after such expiry and the Board may allot equity securities in pursuance of such an offer or agreement as if the power conferred hereby had not expired.

• 17. THAT, subject to the passing of Resolution 16 above, in addition to any authority granted under Resolution 16, the Board be and it is hereby empowered pursuant to Article 27 of the Articles to allot equity securities (within the meaning of Article 25 of the Articles) for cash as if Articles 19–26 of the Articles did not apply to any such allotment provided that this power shall be:
• a. limited to the allotment of equity securities up to an aggregate nominal value of £112,428.27; and
• b. used only for the purposes of financing (or refinancing, if the authority is to be used within six months after the original transaction) a transaction which the Board of the Company determines to be an acquisition or other capital investment of a kind contemplated by the Statement of Principles on Disapplying Pre-Emption Rights most recently published by the Pre-Emption Group prior to the date of this Notice.

This authority shall expire upon the earlier of: (i) the conclusion of the next Annual General Meeting of the Company after passing this resolution; and (ii) 30 June 2026, save that the Company may before such expiry make an offer or agreement which would or might require equity securities to be allotted after such expiry and the Board may allot equity securities in pursuance of such an offer or agreement as if the power conferred hereby had not expired.

On behalf of the Board

Lord Jon Mendelsohn Chairman

Suite 601/701 Europort Europort Road Gibraltar

25 April 2025

Notes

• a. The right to vote at the Meeting and the number of votes a shareholder is entitled to cast at the Meeting are determined by reference to the Company's register of members at 9.00am on Friday 23 May 2025 (or, in the event of any adjournment, on the date not more than 48 hours prior to the time of the adjourned meeting, excluding any part of a day that is not a working day).
• b. A member of the Company entitled to vote at the Meeting is entitled to appoint a proxy to vote instead of him or her. A proxy need not be a member of the Company.
• c. You may submit a proxy appointment or voting instruction online by visiting www.signalshares.com. To be valid, your online proxy appointment and instructions must be received by no later than 9.00am UK time (10.00am Gibraltar time) on 23 May 2025 for Ordinary Shareholders and no later than 9.00am UK time (10.00am Gibraltar time) on 22 May 2025 for Depositary Interest Holders and Employee Shareholders. To vote online you will need to log in to your Signal Shares account or register on the site if you have not already done so. To register on the Signal Shares website you will need your investor code. Once registered you will immediately be able to vote.
• d. VOTE+ is a free app for smartphone and tablet provided by MUFG Corporate Markets (the company's registrar). It offers shareholders the option to submit a proxy appointment quickly and easily online, as well as real-time access to their shareholding records. The app is available to download on both the Apple App Store and Google Play, or by scanning the relevant QR code below.

• e. Alternatively, hard copy forms may be requested from MUFG Corporate Markets on Tel. 0371 664 0300 or by emailing shareholderenquiries@cm.mpms.mufg.com. Calls are charged at the standard geographic rate and will vary by provider. Calls outside the United Kingdom will be charged at the applicable international rate. Lines are open between 9.00am–5.30pm, Monday to Friday excluding public holidays in England and Wales. To be valid, all forms at must be received by the Company's registrar at MUFG Corporate Markets, PXS 1, Central Square, 29 Wellington Street, Leeds LS1 4DL by no later than 9.00am UK time (10.00am Gibraltar time) on 23 May 2025.
• f. A member of the Company may appoint more than one proxy in relation to the Meeting, provided that each proxy is appointed to exercise the rights attaching to a different share or shares held by the member. To do this, a member must complete a separate proxy appointment for each proxy. If you require additional forms, these can be obtained from MUFG Corporate Markets by emailing shareholderenquiries@cm.mpms.mufg.com or by telephone: 0371 664 0300. Calls are charged at the standard geographic rate and will vary by provider. Calls outside the United Kingdom will be charged at the applicable international rate. Lines are open between 9.00am and 5.30pm, Monday to Friday excluding public holidays in England and Wales. A member appointing more than one proxy should indicate on the relevant forms the number of shares for which each proxy is authorised to act on his or her behalf. When two or more valid proxy appointments are delivered or received in respect of the same share, the one which was last delivered or received (regardless of its date or signature) shall be treated as replacing and revoking the others as regards that share; if the Company is unable to determine which was last received, none of them shall be treated as valid in respect of that share.
• g. Unless otherwise indicated on the Form of Proxy or any other electronic voting instruction, the proxy will vote as they think fit or at their discretion or withhold from voting.
• h. If you are a Depositary Interest Holder or Employee Shareholder, your shares are held on your behalf in the name of MUFG Corporate Markets Trustees (Nominees) Limited, who are the registered shareholder. You can tell them how you want the votes in respect of your shares to be cast at the AGM by submitting a voting instruction. This can be done electronically at www.signalshares.com or by completing and returning a hard copy form.

MUFG Corporate Markets Trustees (Nominees) Limited will appoint the chair of the meeting as its proxy to cast your votes. The appointed proxy may also vote or abstain from voting as they think fit on any other business (including amendments to resolutions) which may properly come before the meeting.

i. Holders of Depositary Interests who are CREST members and who wish to submit their instruction through the CREST electronic proxy appointment service may do so for the AGM and any adjournment(s) of the meeting by using the procedures described in the CREST Manual. CREST personal members or other CREST sponsored members, and those CREST members who have appointed a voting service provider(s), should refer to their CREST sponsor or voting service provider(s), who will be able to take the appropriate action on their behalf. The Depositary will appoint the Chair of the meeting as its proxy to cast your votes. The Chair may also vote or abstain from voting as they think fit on any other business (including amendments to resolutions) which may properly come before the meeting.

In order for an instruction made using the CREST service to be valid, the appropriate CREST message (a "CREST Proxy Instruction") must be properly authenticated in accordance with Euroclear UK & International Limited's specifications and must contain the information required for such instructions, as described in the CREST Manual. The message, regardless of whether it constitutes a new instruction or is an amendment to the instruction given to previously, must, in order to be valid, be transmitted so as to be received by the Company's Registrar, MUFG Corporate Markets (CREST Participant ID: RA10), no later than 72 hours before the time appointed for the meeting (excluding weekends and public holidays). For this purpose, the time of receipt will be taken to be the time (as determined by the time stamp applied to the message by the CREST Application Host) from which the Company's Registrar is able to retrieve the message by enquiry to CREST in the manner prescribed by CREST. After this time, any change to instructions through CREST should be communicated through other means.

Notes

CREST members and, where applicable, their CREST sponsor or voting service provider(s) should note that Euroclear UK & International Limited does not make available special procedures in CREST for any particular messages. Normal system timings and limitations will therefore apply in relation to the input of CREST Instructions. It is the responsibility of the CREST member concerned to take (or, if the CREST member is a CREST personal member or sponsored member or has appointed (a) voting service provider(s), to procure that his CREST sponsor or voting service provider(s) take(s)) such action as shall be necessary to ensure that a message is transmitted by means of the CREST system by any particular time. In this regard, CREST members and, where applicable, their CREST sponsor or voting service provider(s) are referred, in particular, to those sections of the CREST Manual concerning practical limitations of the CREST system and timings.

The Company may treat as invalid a CREST Instruction in the circumstances set out in Regulation 35(5)(a) of the Uncertificated Securities Regulations 2001.

• j. If you are an institutional investor, Depositary Interest Holders may also be able to submit an instruction electronically via the Proxymity platform, a process which has been agreed by the Company and approved by the registrar. For further information regarding Proxymity, please go to www.proxymity.io. Your instruction must be lodged by 9.00am on 22 May 2025 in order to be considered valid or, if the Meeting is adjourned, by the time which is 72 hours before the time of the adjourned meeting. Before you can submit an instruction via this process you will need to have agreed to Proxymity's associated terms and conditions. It is important that you read these carefully as you will be bound by them, and they will govern the electronic submission of your instruction. An electronic instruction via the Proxymity platform may be revoked completely by sending an authenticated message via the platform instructing the removal of your submission.
• k. The register of Directors' interests, copies of all Directors' service contracts and appointment letters, and the Memorandum and Articles of Association of the Company will be available for inspection at the registered office of the Company at any time during normal business hours on any weekday (Saturdays, Sundays and public holidays excepted) up to and including the date of the Meeting and at the place of the Meeting for 15 minutes prior to, and during, the Meeting.
• l. As at 28 February 2025 (being the latest practicable date prior to the publication of this Notice) the Company's issued share capital consisted of 449,713,067 Ordinary Shares, carrying one vote each. No shares are held in treasury. Therefore, the total number of voting rights in the Company as at 28 February is 449,713,067. All resolutions put to the Annual General Meeting shall be decided by poll. This will result in a more accurate reflection of the views of shareholders by ensuring that every vote is recognised, including the votes of all shareholders who are unable to attend the Meeting but who appoint a proxy for the Meeting. On a poll, each shareholder has one vote for every share held.
• m. Members are invited to submit any questions in respect of the business of the Meeting for the Board to consider. Questions may be submitted in advance or during the Meeting over the Investor Meet Company platform (https://www.investormeetcompany.com/ evoke-plc/register-investor) following registration, and the Board will aim to respond to any such questions relevant to the business of the Meeting. No answer need be given by the Company to any question if (a) to do so would interfere unduly with the preparation for the Meeting or involve the disclosure of confidential information, or (b) the answer has already been given on a website in the form of an answer to a question, or (c) it is undesirable in the interests of the Company or the good order of the Meeting that the question be answered.
• n. The Company will publish this Notice of Meeting and other relevant information on its corporate website evokeplc.com. Members of the Company can require the publication of a statement on the Company's corporate website, setting out any matter that the members propose to raise at the Meeting, regarding the audit of the Company's accounts that are to be laid before the Meeting, or any circumstances connected with an auditor of the Company ceasing to hold office since the last Annual General Meeting of the Company.
• o. Any member has the right to require the Company to give notice of a resolution or other business to be dealt with at the Meeting pursuant to the Gibraltar Listed Companies (Members' Rights) Regulations 2011.

This page intentionally left blank

evoke plc Registered office

Suite 601/701 Europort Europort Road Gibraltar

Registered in Gibraltar with company number 90099

corporate.secretary@evokeplc.com

t: +350 200 48571

evokeplc.com